These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 9600123)
21. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer. Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461 [TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma. Rice LW; Jazaeri AA; Shupnik MA Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405 [TBL] [Abstract][Full Text] [Related]
23. Alternative exon-specific PCR method for the analysis of human CD44 isoform expression. Lockhart MS; Gravisaco MJ; Mongini C; Waldner C; Alvarez E; Hajos SE Oncol Rep; 1999; 6(1):219-24. PubMed ID: 9864432 [TBL] [Abstract][Full Text] [Related]
24. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants. Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309 [TBL] [Abstract][Full Text] [Related]
25. A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Legras S; Günthert U; Stauder R; Curt F; Oliferenko S; Kluin-Nelemans HC; Marie JP; Proctor S; Jasmin C; Smadja-Joffe F Blood; 1998 May; 91(9):3401-13. PubMed ID: 9558399 [TBL] [Abstract][Full Text] [Related]
26. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713 [TBL] [Abstract][Full Text] [Related]
27. CD44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation. Yanagisawa N; Mikami T; Mitomi H; Saegusa M; Koike M; Okayasu I Cancer; 2001 Jan; 91(2):408-16. PubMed ID: 11180088 [TBL] [Abstract][Full Text] [Related]
28. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas. Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106 [TBL] [Abstract][Full Text] [Related]
29. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy. Kallakury BV; Yang F; Figge J; Smith KE; Kausik SJ; Tacy NJ; Fisher HA; Kaufman R; Figge H; Ross JS Cancer; 1996 Oct; 78(7):1461-9. PubMed ID: 8839552 [TBL] [Abstract][Full Text] [Related]
30. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7. Fang XJ; Jiang H; Zhao XP; Jiang WM BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678 [TBL] [Abstract][Full Text] [Related]
31. Phosphorylation stabilizes alternatively spliced CD44 mRNA transcripts in breast cancer cells: inhibition by antisense complementary to casein kinase II mRNA. Formby B; Stern R Mol Cell Biochem; 1998 Oct; 187(1-2):23-31. PubMed ID: 9788739 [TBL] [Abstract][Full Text] [Related]
32. CD44 isoform expression in the diffuse neuroendocrine system. II. Benign and malignant tumors. Komminoth P; Seelentag WK; Saremaslani P; Heitz PU; Roth J Histochem Cell Biol; 1996 Dec; 106(6):551-62. PubMed ID: 8985743 [TBL] [Abstract][Full Text] [Related]
33. The role of alternative splicing of the adhesion molecule, CD44, in lymphoid malignancy. Irving JA; Cain G; Howard M; Angus B; Taylor PR; Cattan AR J Clin Pathol; 1998 Oct; 51(10):776-80. PubMed ID: 10023342 [TBL] [Abstract][Full Text] [Related]
34. Expression of two isoforms of CD44 in human endometrium. Behzad F; Seif MW; Campbell S; Aplin JD Biol Reprod; 1994 Oct; 51(4):739-47. PubMed ID: 7529574 [TBL] [Abstract][Full Text] [Related]
35. Expression of CD44 variant 6 and its prognostic value in benign and malignant endometrial tissue. Kansu-Celik H; Gungor M; Ortac F; Kankaya D; Ensari A Arch Gynecol Obstet; 2017 Aug; 296(2):313-318. PubMed ID: 28620808 [TBL] [Abstract][Full Text] [Related]
36. CD44 expression in cervical intraepithelial neoplasia (CIN) and carcinoma. Gorham H; Woodman A; Goodison S; Marsh J; Charnock M; Manek S; Sugino T; Tarin D Mol Diagn; 1999 Mar; 4(1):45-56. PubMed ID: 10229774 [TBL] [Abstract][Full Text] [Related]
37. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Stauder R; Van Driel M; Schwärzler C; Thaler J; Lokhorst HM; Kreuser ED; Bloem AC; Günthert U; Eisterer W Blood; 1996 Oct; 88(8):3101-8. PubMed ID: 8874209 [TBL] [Abstract][Full Text] [Related]
38. SR proteins regulate V6 exon splicing of CD44 pre-mRNA. Loh TJ; Moon H; Jang HN; Liu Y; Choi N; Shen S; Williams DR; Jung DW; Zheng X; Shen H BMB Rep; 2016 Nov; 49(11):612-616. PubMed ID: 27530682 [TBL] [Abstract][Full Text] [Related]
39. Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3. Vela E; Hilari JM; Roca X; Muñoz-Mármol AM; Ariza A; Isamat M RNA; 2007 Dec; 13(12):2312-23. PubMed ID: 17940137 [TBL] [Abstract][Full Text] [Related]
40. Ratio of CD44 epithelial variant to CD44 hematopoietic variant is a useful prognostic indicator in gastric and colorectal carcinoma. Shibuya Y; Okabayashi T; Oda K; Tanaka N Jpn J Clin Oncol; 1998 Oct; 28(10):609-14. PubMed ID: 9839501 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]